ArticleTheranostics2026
Intermittent hypoxia ameliorates behavioral deficits and exerts neurorestoration in a mouse photothrombotic stroke model.
Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ischemic stroke disproportionately impacts the elderly with a higher risk and poor repair. Current therapeutic options are constrained by narrow time windows, strict contraindications, and suboptimal efficacy in older patients, leaving a critical unmet clinical need. Hypoxia-based interventions exert preclinical neuroprotective effects, yet the effects and underlying mechanisms of intermittent hypoxia (IH) in elderly patients with ischemic stroke remain unclear. Methods: This study tested IH in 25-month-old C57BL/6J mice with photothrombotic (PT) stroke, randomizing to Control, PT, or PT+IH groups. IH post-conditioning was administered a total of 7 sessions on days 3-16. One session consists of a 10-min phase with 8% oxygen, followed by a 10-min phase with room air. Behavioral changes were measured through the maximal grip strength test, beam balance test, cylinder test, adhesive removal test, grid-walking test, and open field test. Neuropathological changes and potential molecular mechanisms were analyzed via immunofluorescence staining and western blotting. Results: Our findings demonstrated that IH treatment significantly reduced cortical infarct volume and ameliorated PT-induced sensorimotor deficits in aged mice. Furthermore, IH alleviated neuronal damage and apoptosis, preserved cerebrovascular morphology, and attenuated excessive astrocyte-vasculature interactions. Mechanistically, IH upregulated astrocyte-specific hypoxia-inducible factor 1α (HIF-1α), mitigated mitochondrial fragmentation, and shifted the polarization of microglia and astrocytes from pro-inflammatory (M1/A1) to anti-inflammatory (M2/A2) phenotypes. Collectively, these effects contributed to enhanced neurogenesis and angiogenesis in the peri-infarct region. Conclusion: In conclusion, these findings confirm IH's neurorestoration in aged stroke mice, potentially via HIF-1α-related regulation of mitochondrial function, glial polarization, and vascular integrity, supporting its translational potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.